Currently predicting for Thu, 4 Jun 2026

MNKD Prediction Chart

MNKD Predictions History

Latest community submissions for MNKD.
Predictor Target Session Target Price Result Direction Accuracy Score
May 31, 2017 $0.523 -65.59% $1.52 X 34.40% 0
JS JS Pro
May 11, 2017 $1.80 +41.18% $1.27 X 58.80% 0
JS JS Pro
May 9, 2017 $0.93 -16.96% $1.12 X 83.00% 0
JS JS Pro
Mar 15, 2017 $2.09 +3.47% $2.02 X 96.50% 0
Brinda Brinda @Brinda.4269
Mar 15, 2017 $1.83 -9.41% $2.02 X 90.60% 0
Mar 15, 2017 $2.08 +2.97% $2.02 X 97.00% 0
Mar 15, 2017 $2.97 +47.03% $2.02 X 53.00% 0
Mar 9, 2017 $2.04 +5.15% $1.94 X 94.80% 0
Mar 3, 2017 $0.790 -62.82% $2.12 V 37.20% 0
Feb 1, 2017 $0.720 -79.75% $0.710 V 98.70% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MNKD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MANNKIND CORPORATION
MannKind
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a licens...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE